Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
As of close of business last night, Adma Biologics Inc’s stock clocked out at $6.93, up 1.02% from its previous closing price of $6.86. In other words, the price has increased by $1.02 from its previous closing price. On the day, 2.79 million shares were traded. ADMA stock price reached its highest trading level at $6.97 during the session, while it also had its lowest trading level at $6.84.
Ratios:
To gain a deeper understanding of ADMA’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 31.28 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 398.55. For the most recent quarter (mrq), Quick Ratio is recorded 1.69 and its Current Ratio is at 5.16. In the meantime, Its Debt-to-Equity ratio is 1.05 whereas as Long-Term Debt/Eq ratio is at 1.04.
On October 13, 2022, Mizuho started tracking the stock assigning a Buy rating and target price of $5.
Raymond James Upgraded its Outperform to Strong Buy on November 11, 2021, while the target price for the stock was maintained at $5.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 19 ’24 when ELMS STEVE sold 411,829 shares for $6.08 per share. The transaction valued at 2,503,920 led to the insider holds 2,115,671 shares of the business.
ELMS STEVE sold 49,887 shares of ADMA for $299,821 on Mar 18 ’24. The Director now owns 2,527,500 shares after completing the transaction at $6.01 per share. On Mar 15 ’24, another insider, ELMS STEVE, who serves as the Director of the company, sold 183,008 shares for $6.01 each. As a result, the insider received 1,099,878 and left with 2,577,387 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADMA now has a Market Capitalization of 1606179968 and an Enterprise Value of 1655656832. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.22 while its Price-to-Book (P/B) ratio in mrq is 11.59. Its current Enterprise Value per Revenue stands at 6.412 whereas that against EBITDA is 50.547.
Stock Price History:
Over the past 52 weeks, ADMA has reached a high of $6.97, while it has fallen to a 52-week low of $3.06. The 50-Day Moving Average of the stock is 10.46%, while the 200-Day Moving Average is calculated to be 48.39%.
Shares Statistics:
It appears that ADMA traded 2.59M shares on average per day over the past three months and 2112450 shares per day over the past ten days. A total of 226.06M shares are outstanding, with a floating share count of 222.93M. Insiders hold about 3.82% of the company’s shares, while institutions hold 75.89% stake in the company. Shares short for ADMA as of 1713139200 were 8106148 with a Short Ratio of 3.14, compared to 1710460800 on 7993583. Therefore, it implies a Short% of Shares Outstanding of 8106148 and a Short% of Float of 3.5999999999999996.
